Immunization, Hib3 in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Immunization, Hib3 was 93.2% in 2024. ◆ Volatile
Immunization, Hib3 in Europe & Central Asia (excluding high income), 1992–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Europe & Central Asia (excluding high income) recorded 93.2% for immunization, hib3 in 2024.
The figure is down 1.5% on the previous year and up 8.3% over ten years.
Over the whole period, immunization, hib3 in Europe & Central Asia (excluding high income) peaked at 94.6% in 2019 and was at its lowest, 0.0%, in 1992.
Europe & Central Asia (excluding high income) ranks 6th of 43 groups on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Europe & Central Asia (excluding high income), year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.0% | — |
| 1998 | 0.0% | — |
| 1999 | 0.0% | — |
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.6% | — |
| 2005 | 0.6% | -1.2% |
| 2006 | 3.3% | +469.7% |
| 2007 | 35.8% | +968.7% |
| 2008 | 53.9% | +50.8% |
| 2009 | 76.5% | +41.9% |
| 2010 | 81.1% | +6.0% |
| 2011 | 81.6% | +0.7% |
| 2012 | 92.4% | +13.2% |
| 2013 | 93.0% | +0.6% |
| 2014 | 86.0% | -7.5% |
| 2015 | 86.8% | +0.9% |
| 2016 | 87.3% | +0.6% |
| 2017 | 87.2% | -0.1% |
| 2018 | 91.5% | +5.0% |
| 2019 | 94.6% | +3.3% |
| 2020 | 92.5% | -2.2% |
| 2021 | 92.7% | +0.3% |
| 2022 | 93.7% | +1.1% |
| 2023 | 94.5% | +0.9% |
| 2024 | 93.2% | -1.5% |
Biggest year-on-year movements
Years where Immunization, Hib3 in Europe & Central Asia (excluding high income) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2007 | +968.7% | 3.3% | 35.8% |
| 2006 | +469.7% | 0.6% | 3.3% |
| 2008 | +50.8% | 35.8% | 53.9% |
| 2009 | +41.9% | 53.9% | 76.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | 8 |
| 2000s | 17.1% | 0.0% | 76.5% | 10 |
| 2010s | 88.2% | 81.1% | 94.6% | 10 |
| 2020s | 93.3% | 92.5% | 94.5% | 5 |
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is immunization, hib3 in Europe & Central Asia (excluding high income)?
- Immunization, hib3 in Europe & Central Asia (excluding high income) was 93.2% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 94.6% in 2019.
- What is the lowest immunization, hib3 recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 0.0% in 1992.
- How does Europe & Central Asia (excluding high income) rank for immunization, hib3?
- Europe & Central Asia (excluding high income) ranks 6th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is up 8.3%. The long-run trend across the full record is volatile.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.